Last A$0.0040 AUD
Change Today 0.00 / 0.00%
Volume 4.2M
BPO On Other Exchanges
As of 10:43 PM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

bioprospect ltd (BPO) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/16/13 - A$0.0050
52 Week Low
09/2/13 - A$0.0010
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIOPROSPECT LTD (BPO)

Related News

No related news articles were found.

bioprospect ltd (BPO) Related Businessweek News

No Related Businessweek News Found

bioprospect ltd (BPO) Details

BioProspect Limited is engaged in the research, development, and commercialization of natural products and technology in the human health and personal care, animal health and nutrition, and agricultural sectors in Australia and internationally. The company offers agriculture/animal health products comprising Qcide, a natural insecticide for controlling hygiene insects, including flies, mosquitoes, and ants; AGRIPRO topical gel for the treatment of surface wounds and abrasions, and skin conditions; and GI-GUARD oral paste for horses. It also provides human health/skin care products, such as DEMURE natural skin care products, and L'AZURE cosmetics; and therapeutic products, including pain relief sprays and gels, and emu oil capsules under the REGEN brand. In addition, the company is involved in the oil and gas exploration and development activities primarily in the Philippines. BioProspect Limited was founded in 1998 and is based in Nedlands, Australia.

Founded in 1998

bioprospect ltd (BPO) Top Compensated Officers

Chief Financial Officer and Secretary
Total Annual Compensation: A$53.3K
Compensation as of Fiscal Year 2013.

bioprospect ltd (BPO) Key Developments

BioProspect Ltd. Appoints Stephen Pearce as Advisor

The Board of BioProspect Ltd. appointed Mr. Stephen Pearce as an adviser to assist in its next important phase of development. Mr. Pearce is the Chief Financial Officer of Fortescue Metals Group Ltd. having joined Fortescue in March 2010. Mr. Pearce is also Non-Executive Chairman of the Lion's Eye Institute, a leading Eye Research Institute based in Perth, Western Australia. Mr. Pearce will provide strategic, commercial and corporate guidance to the Board of BPO. Mr. Pearce will advise the Board through this important phase of development funding and commercialisation in addition to the establishment of a Medical Advisory Board and assistance in the appointment of new Board members as the company enters into the next phase of growth.

BioProspect Announces Board Changes

BioProspect announced the appointment of Kris Knauer as an Executive Director. Kris has a wealth of experience particularly in ASX Listed companies and is also a key shareholder and convertible noteholder of the Company. Kris has been a consultant to the Company and has been actively involved in the due diligence process and subsequently in providing corporate and strategic advice to BioProspect. Kris' will focus corporate matters such as the Board and Senior Management composition and structure, Capital structure, and the ongoing funding requirements for commercialization of Invatec's HRV technology for the diagnosis of Depression and other Mental Health conditions. Peter May has resigned from the board effective from the June 30, 2014. Mr. May will continue to be a consultant to BPO so as to assist in the strategic direction of the technology that relates to the human health and personal care, animal health and nutrition and agricultural sectors.

BioProspect Ltd. expected to report Fiscal Year 2014 results on August 29, 2014. This event was calculated by Capital IQ (Created on May 22, 2014).

BioProspect Ltd. expected to report Fiscal Year 2014 results on August 29, 2014. This event was calculated by Capital IQ (Created on May 22, 2014).


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BPO:AU A$0.00 AUD 0.00

BPO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BPO.
View Industry Companies

Industry Analysis


Industry Average

Valuation BPO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 26.0x
Price/Book 4.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 24.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOPROSPECT LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at